CRISPR Based Technologies and Bio-products

CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defence system of prokaryote. Cas9 (or "CRISPR-associated protein 9") is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases

  • CRISPR-CAS 9 gene editing technology
  • Clinical and healthcare aspects of CRISPR genome editing
  • Implementation of CRISPR screening technique in drug discovery
  • Social, ethical and economic implications of CRISPR-based technology
  • CRISPR for developing better antibiotics

Related Conference of CRISPR Based Technologies and Bio-products

November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

Lisbon, Portugal | Holiday Inn Lisbon-Continental Rua Laura Alves 9, 1069-169 Lisboa, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK

CRISPR Based Technologies and Bio-products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in